Australia pledges Aus$292m for medical research:
This article was originally published in Clinica
Australia has pledged Aus$292m (US$221m) in a first round of funding for medical research to commence in 2006. In all, 600 projects will be conducted across 52 institutions, including universities, hospitals and medical research institutes. Some of the projects relevant to medical technology include: prostate cancer outcomes study; study on cervical health; developing a new patient-centred adverse event reporting tool; and a follow-up of the International Breast Cancer Intervention Study (a prevention trial for women at high risk). A full list of the projects and funding amounts can be found at: www.nhmrc.gov.au/funding/fundedoutcomes/index.htm
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.